MeSH D002056 - burns
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014947:Wounds and injuries
D002056:Â
Burns
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Lidocaine | Lidocaine |  | 1982-01-01 |  |  |
| Abbott Biotherapeutics | Lidocaine | Lidocaine |  | 1983-02-02 |  |  |
| Lidocaine, Epinephrine | Lidocaine W/ Epinephrine |  | 1982-01-01 |  |  | |
| Lidocaine | Lta |  | 1984-07-31 |  |  | |
| Afaxys | Lidocaine | Lidocaine |  | 2022-06-09 |  |  |
| Alcon Research | Povidone-iodine | Betadine |  | 1986-12-17 |  |  |
| Alembic Pharmaceuticals | Lidocaine | Lidocaine |  | 2018-11-23 |  |  |
| Lidocaine, Prilocaine | Lidocaine Prilocaine |  | 2022-04-08 |  |  | |
| Alkem Laboratories | Lidocaine | Lidocaine |  | 2017-03-10 |  |  |
| Allegiance Healthcare | Povidone-iodine | Povidone |  | 1989-03-31 |  |  |
| Allergan | Lidocaine | Lidocaine |  | 2011-03-23 |  |  |
| Lidocaine | Lidocaine Viscous |  | 1982-01-01 |  |  | |
| Lidocaine, Epinephrine | Lidocaine W/ Epinephrine |  | 1982-01-01 |  |  | |
| American Regent | Lidocaine | Lidocaine |  | 1982-01-01 |  |  |
| Amneal Pharmaceuticals | Lidocaine | Lidocaine |  | 2015-08-07 | $8.685 M | Y2017 |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
64%9/14
Phase 2
64%27/42
Phase 3
33%19/57
Approved: 7Overall Success rate: 14%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use